Levitra (APHENA PHARMA SOLUTIONS – TENNESSEE, INC.)


Welcome to the PulseAid listing for the Levitra drug offered from APHENA PHARMA SOLUTIONS – TENNESSEE, INC.. This Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: APHENA PHARMA SOLUTIONS – TENNESSEE, INC.
NON-PROPRIETARY NAME: vardenafil hydrochloride
SUBSTANCE NAME: VARDENAFIL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-05-15
END MARKETING DATE: 0000-00-00


Levitra HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLevitra from APHENA PHARMA SOLUTIONS – TENNESSEE, INC.
LABELER NAME: APHENA PHARMA SOLUTIONS – TENNESSEE, INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/1)
START MARKETING DATE: 2008-05-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43353-323_741bda18-742a-4192-b37c-41680ca38343
PRODUCT NDC: 43353-323
APPLICATION NUMBER: NDA021400

Other VARDENAFIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
APHENA PHARMA SOLUTIONS – TENNESSEE, INC.Levitra
GlaxoSmithKline LLCStaxyn
KAISER FOUNDATION HOSPITALSLEVITRA
Physicians Total Care, Inc.Levitra